Zaloguj się

Gotowe bibliografie tematyczne / Screening of Breast Cancer / Artykuły w czasopismach

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Screening of Breast Cancer.

Artykuły w czasopismach na temat „Screening of Breast Cancer”

Autor: Grafiati

Data publikacji: 6 września 2023

Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Screening of Breast Cancer”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Yamauchi, Hideko. "Breast Cancer Screening System in USA." Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) 21, no. 2 (2012): 115–26. http://dx.doi.org/10.3804/jjabcs.21.115.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Gordon, Paula B. "The Impact of Dense Breasts on the Stage of Breast Cancer at Diagnosis: A Review and Options for Supplemental Screening." Current Oncology 29, no. 5 (2022): 3595–636. http://dx.doi.org/10.3390/curroncol29050291.

Pełny tekst źródła

Streszczenie:

The purpose of breast cancer screening is to find cancers early to reduce mortality and to allow successful treatment with less aggressive therapy. Mammography is the gold standard for breast cancer screening. Its efficacy in reducing mortality from breast cancer was proven in randomized controlled trials (RCTs) conducted from the early 1960s to the mid 1990s. Panels that recommend breast cancer screening guidelines have traditionally relied on the old RCTs, which did not include considerations of breast density, race/ethnicity, current hormone therapy, and other risk factors. Women do not all

Style APA, Harvard, Vancouver, ISO itp.

3

Arima, Yuriko. "Breast Cancer Screening Programme in the UK." Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) 21, no. 2 (2012): 127–37. http://dx.doi.org/10.3804/jjabcs.21.127.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Chou, Yi-Hong. "Evolution of Breast Cancer Screening in Taiwan." Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) 21, no. 2 (2012): 138–42. http://dx.doi.org/10.3804/jjabcs.21.138.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Schouten, L. J., J. Th Schlangen, J. M. de Rijke, and A. L. M. Verbeek. "Evaluation of the effect of breast cancer screening by record linkage with the cancer registry, the Netherlands." Journal of Medical Screening 5, no. 1 (1998): 37–41. http://dx.doi.org/10.1136/jms.5.1.37.

Pełny tekst źródła

Streszczenie:

Objective To evaluate the effect of a breast cancer screening programme by record linkage with the cancer registry. Setting Breast cancer screening programme in mid- and southern Limburg, the Netherlands. Method The data files of the breast cancer screening programme and the Maastricht Cancer Registry were linked in order to evaluate the effect of breast cancer screening. Only the first primary breast tumour was included in the evaluation. Results From 1990 until 1995 90 001 women participated in the first round of the breast cancer screening programme and 64 637 in subsequent rounds. After th

Style APA, Harvard, Vancouver, ISO itp.

6

Watkins, Elyse, and Toni Jackson. "Implications of breast density for breast cancer screening." JAAPA 37, no. 10 (2024): 32–35. http://dx.doi.org/10.1097/01.jaa.0000000000000127.

Pełny tekst źródła

Streszczenie:

ABSTRACT Extremely dense breasts can be an independent risk factor for breast cancer. A new FDA rule requires that patients be notified of their breast density and the possible benefits of additional imaging to screen for breast cancer. Clinicians should be cognizant of the data about breast cancer risk, breast density, and recommendations to change screening techniques if patients, particularly premenopausal females, have extremely dense breasts but no other known risk factors.

Style APA, Harvard, Vancouver, ISO itp.

7

Mahmoud, Mattia A., Sarah Ehsan, Oluwadamilola M. Fayanju, et al. "Abstract C118: Racial disparities in insurance coverage for supplemental breast cancer screening." Cancer Epidemiology, Biomarkers & Prevention 32, no. 12_Supplement (2023): C118. http://dx.doi.org/10.1158/1538-7755.disp23-c118.

Pełny tekst źródła

Streszczenie:

Abstract Introduction and Purpose: Women with dense breasts have increased risk both for developing breast cancer and false-negative mammograms. Supplemental screening with breast MRI has been shown to shown to significantly increase cancer detection among women with dense breasts. In May 2023, Pennsylvania (PA) mandated insurance coverage of one supplemental screening study (breast MRI or ultrasound ) annually for women with dense breasts. Prior research suggests that Black women have lower breast density on average than white women based on subjective grading from the American College of Rad

Style APA, Harvard, Vancouver, ISO itp.

8

AIRES LIMA, Cátia Cilene, and Carla Daruich de Souza. "Evaluation of the Possible Benefits of Breast Cancer Screening in Women Aged 40 to 49 Years in the Steel Valley Region, Brazil." Archives of Breast Cancer 11, no. 2 (2024): 172–82. http://dx.doi.org/10.32768/abc.2024112172-182.

Pełny tekst źródła

Streszczenie:

Background: This study investigates the effectiveness of mammographic screening for women aged 40 to 49 in Brazil's Steel Valley Region. Despite a Ministry of Health recommendation to start screenings at 50, 25% of breast cancer cases occur in the 40-49 age group. Methods: The retrospective analysis, spanning 2008-2019 at Marcio Cunha Hospital, compared two groups: cancer diagnosed via screening mammography (277) and diagnostic mammography (229). Results: Results showed delayed diagnoses for non-screened women, with 4.16 times higher mortality rate. Screening facilitated earlier detection of l

Style APA, Harvard, Vancouver, ISO itp.

9

Ding, Rui, Yi Xiao, Miao Mo, Ying Zheng, Yi-Zhou Jiang, and Zhi-Ming Shao. "Breast cancer screening and early diagnosis in Chinese women." Cancer Biology & Medicine 19, no. 4 (2022): 450–67. http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0676.

Pełny tekst źródła

Streszczenie:

Breast cancer is the most common malignant tumor in Chinese women, and its incidence is increasing. Regular screening is an effective method for early tumor detection and improving patient prognosis. In this review, we analyze the epidemiological changes and risk factors associated with breast cancer in China and describe the establishment of a screening strategy suitable for Chinese women. Chinese patients with breast cancer tend to be younger than Western patients and to have denser breasts. Therefore, the age of initial screening in Chinese women should be earlier, and the importance of scr

Style APA, Harvard, Vancouver, ISO itp.

10

Calinescu, Gina, Corina Grigoriu, Athir Eddan, et al. "Breast density and breast cancer." Romanian Journal of Medical Practice 16, S7 (2021): 29–32. http://dx.doi.org/10.37897/rjmp.2021.s7.9.

Pełny tekst źródła

Streszczenie:

Breast density is increasingly recognized as an independent risk factor for the development of breast cancer. It has been shown to be associated with a four-to sixfold increase a woman's risk of malignant breast disease. Increased breast density, as identified on mammography, is known to decrease the diagnostic sensitivity of the examination, which is of great concern to women at increased risk for breast cancer. Dense tissue has generally been associated with younger age and premenopausal status, with the assumption that breast density gradually decreases after menopause. However, the actual

Style APA, Harvard, Vancouver, ISO itp.

11

Reungwetwattana, Thanyanan, Julian R. Molina, and Jeanette Y. Ziegenfuss. "Factors and trends in cancer screening in the United States from 2004 to 2010." Journal of Clinical Oncology 30, no. 15_suppl (2012): 1565. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1565.

Pełny tekst źródła

Streszczenie:

1565 Background: Understanding the prevalence of cancer screening in the US and the factors associated with its accessibility is important for public health promotion. Methods: The 2004 and 2010 Behavioral Risk Factor Surveillance Systems were used to ascertain cancer screening rates among populations indicated for each test by age, gender, and the American Cancer Society recommendation for cancer screenings [fecal occult blood test (FOBT) or endoscopy for colorectal cancer (CRC) screening, digital rectal examination (DRE) or prostate specific antigen (PSA) for prostate cancer screening, clini

Style APA, Harvard, Vancouver, ISO itp.

12

P., Priyadarshini,, Sarathi, S., and Hemavathy, V. "Breast Cancer Screening." CARDIOMETRY, no. 24 (November 30, 2022): 1000–1005. http://dx.doi.org/10.18137/cardiometry.2022.24.10001005.

Pełny tekst źródła

Streszczenie:

Breast cancer is the most frequent cancer in women, impacting one out of every eight women at some point in their lives. Despite the fact that it is more frequent in older women, breast cancer seldom strikes women under the age of 45. Women under the age of 45 account for around 9% of all new cases of breast cancer in the United States. The most important methods for preventing breast cancer deaths are early detection and cutting-edge cancer treatment. Breast cancer that is detected early, when it is little and hasn’t spread, is easier to treat. The most accurate method for identifying breast

Style APA, Harvard, Vancouver, ISO itp.

13

Zheng, Senshuang, Xiaorui Zhang, Marcel J. W. Greuter, Geertruida H. de Bock, and Wenli Lu. "Determinants of Population-Based Cancer Screening Performance at Primary Healthcare Institutions in China." International Journal of Environmental Research and Public Health 18, no. 6 (2021): 3312. http://dx.doi.org/10.3390/ijerph18063312.

Pełny tekst źródła

Streszczenie:

Background: For a decade, most population-based cancer screenings in China are performed by primary healthcare institutions. To assess the determinants of performance of primary healthcare institutions in population-based breast, cervical, and colorectal cancer screening in China. Methods: A total of 262 primary healthcare institutions in Tianjin participated in a survey on cancer screening. The survey consisted of questions on screening tests, the number of staff members and training, the introduction of the screening programs to residents, the invitation of residents, and the number of perfo

Style APA, Harvard, Vancouver, ISO itp.

14

Lynge, Elsebeth, Ilse Vejborg, Zorana Andersen, My von Euler-Chelpin, and George Napolitano. "Mammographic Density and Screening Sensitivity, Breast Cancer Incidence and Associated Risk Factors in Danish Breast Cancer Screening." Journal of Clinical Medicine 8, no. 11 (2019): 2021. http://dx.doi.org/10.3390/jcm8112021.

Pełny tekst źródła

Streszczenie:

Background: Attention in the 2000s on the importance of mammographic density led us to study screening sensitivity, breast cancer incidence, and associations with risk factors by mammographic density in Danish breast cancer screening programs. Here, we summarise our approaches and findings. Methods: Dichotomized density codes: fatty, equal to BI-RADS density code 1 and part of 2, and other mixed/dense data from the 1990s—were available from two counties, and BI-RADS density codes from one region were available from 2012/13. Density data were linked with data on vital status, incident breast ca

Style APA, Harvard, Vancouver, ISO itp.

15

Nigam, Aruna, and Neeti Singhal. "Breast Cancer Screening: Guidelines and Opportunities for Gynecologists." Journal of Colposcopy and Lower Genital Tract Pathology 2, no. 2 (2024): 45–50. http://dx.doi.org/10.4103/jclgtp.jclgtp_13_24.

Pełny tekst źródła

Streszczenie:

Abstract Breast cancer is the most common cancer worldwide and is the leading cause of deaths from cancer among women. It accounts for 12% of all cancer cases worldwide and 39.4% of the total cancer cases in women in India. The number is expected to rise to more than 2.3 lakh cases by the year 2025. As a general instinct, females usually come to gynecologists with problems related to breasts apart from other gynecological problems. Hence, they play a vital role in early detection by identifying the high-risk patients, screening them and spreading awareness. Risk factors for each age group shou

Style APA, Harvard, Vancouver, ISO itp.

16

Bukhari, Hassan, Asim Shaukat, and Nosheen Ahmad. "BREAST CANCER SCREENING;." Professional Medical Journal 24, no. 01 (2017): 42–46. http://dx.doi.org/10.29309/tpmj/2017.24.01.400.

Pełny tekst źródła

Streszczenie:

Objectives: To compare the efficacy of Magnetic resonance imaging andMammography for Breast-Cancer Screening in high risk Women with a Familial or GeneticPredisposition. Study Design: Cross-sectional study. Setting: Department of Radiology AlliedHospital, Faisalabad. Duration: From January 2012 to December 2014, Sample size: 299.Methods: A total of 299 females at high risk of breast cancer were included in this study andthey underwent screening rounds of Mammogram and contrast enhanced dynamic breastMRI once a year with independent readings. Both the imaging modalities were interpreted byexper

Style APA, Harvard, Vancouver, ISO itp.

17

Leung, Jessica, Olena Weaver, Samir Hanash, and Jennifer Dennison. "Abstract P6-03-01: The MERIT Cohort: An MD Anderson Initiative to Integrate Blood and Imaging Biomarkers to Personalize Breast Cancer Risk." Cancer Research 83, no. 5_Supplement (2023): P6–03–01—P6–03–01. http://dx.doi.org/10.1158/1538-7445.sabcs22-p6-03-01.

Pełny tekst źródła

Streszczenie:

Abstract Background: The MERIT cohort (Mammography, Early Detection, Risk Assessment, and Imaging Technologies, 2017-present) has enrolled women receiving annual screening mammograms (MG) at MD Anderson with a primary goal to integrate clinical data and imaging data with blood biomarker profiles to determine risk of developing breast and other cancers. Here we report interim results for breast cancers among post-menopausal women in the cohort categorized based on breast density and BMI and differences between participants who underwent MRI/MG screening vs standard annual MG screening. Methods:

Style APA, Harvard, Vancouver, ISO itp.

18

Huang, Sida, Sarah J. Westvold, Pamela R. Soulos, et al. "Screening History, Stage at Diagnosis, and Mortality in Screen-Detected Breast Cancer." JAMA Network Open 8, no. 4 (2025): e255322. https://doi.org/10.1001/jamanetworkopen.2025.5322.

Pełny tekst źródła

Streszczenie:

ImportanceScreening mammography promotes early detection of breast cancer and is associated with reduced breast cancer mortality. Screening history prior to diagnosis may impact stage at diagnosis and breast cancer mortality but has not been comprehensively examined within a diverse US cohort.ObjectiveTo determine whether having a prior screening is associated with earlier stage at breast cancer diagnosis and lower breast cancer–specific mortality.Design, Setting, and ParticipantsThis cohort study used linked Surveillance, Epidemiology, and End Results–Medicare data of women aged at least 70 y

Style APA, Harvard, Vancouver, ISO itp.

19

Kuhl, Christiane K., Heribert Bieling, Kevin Strobel, Claudia Leutner, Hans H. Schild, and Simone Schrading. "Breast MRI screening of women at average risk of breast cancer: An observational cohort study." Journal of Clinical Oncology 33, no. 28_suppl (2015): 1. http://dx.doi.org/10.1200/jco.2015.33.28_suppl.1.

Pełny tekst źródła

Streszczenie:

1 Background: Breast-MRI is currently recommended for screening women at high-risk of breast-cancer only. However, despite decades of mammographic-screening, breast-cancer continues to represent a major cause of cancer-death also for women at average-risk – suggesting a need for improved methods for early diagnosis also for these women. Therefore, we investigated the utility of supplemental MRI-screening of women who carry an average-risk of breast-cancer. Methods: Prospective observational cohort-study conducted in two academic breast-centers on asymptomatic women at average-risk in the usual

Style APA, Harvard, Vancouver, ISO itp.

20

Barton, Mary B. "Breast cancer screening." Postgraduate Medicine 118, no. 2 (2005): 27–46. http://dx.doi.org/10.3810/pgm.2005.08.1692.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Zorbas, Helen M. "Breast cancer screening." Medical Journal of Australia 178, no. 12 (2003): 651–52. http://dx.doi.org/10.5694/j.1326-5377.2003.tb05397.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Warner, Elizabeth A. "BREAST CANCER SCREENING." Primary Care: Clinics in Office Practice 19, no. 3 (1992): 575–88. http://dx.doi.org/10.1016/s0095-4543(21)00939-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Cooper, Nora. "Breast cancer screening." Nursing Standard 13, no. 31 (1999): 49–52. http://dx.doi.org/10.7748/ns1999.04.13.31.49.c7471.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Freimanis, Rita I., and Margaret Yacobozzi. "Breast Cancer Screening." North Carolina Medical Journal 75, no. 2 (2014): 117–20. http://dx.doi.org/10.18043/ncm.75.2.117.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Tabár, László, and Peter B. Dean. "Breast cancer screening." Medical Journal of Australia 154, no. 7 (1991): 494. http://dx.doi.org/10.5694/j.1326-5377.1991.tb121204.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Kearsley, John H., and Cherrell Hirst. "Breast cancer screening." Medical Journal of Australia 154, no. 7 (1991): 494. http://dx.doi.org/10.5694/j.1326-5377.1991.tb121205.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Cohen, Jonathan, and Joseph Cohen. "Breast cancer screening." Medical Journal of Australia 154, no. 7 (1991): 494. http://dx.doi.org/10.5694/j.1326-5377.1991.tb121206.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Freilich, Herbert. "Breast cancer screening." Medical Journal of Australia 154, no. 11 (1991): 781–82. http://dx.doi.org/10.5694/j.1326-5377.1991.tb121347.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Tabár, László, and Peter B. Dean. "Breast cancer screening." Medical Journal of Australia 154, no. 12 (1991): 853–54. http://dx.doi.org/10.5694/j.1326-5377.1991.tb121395.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Warner, Ellen. "Breast-Cancer Screening." New England Journal of Medicine 365, no. 11 (2011): 1025–32. http://dx.doi.org/10.1056/nejmcp1101540.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Ellman, Ruth. "Breast Cancer Screening." Journal of the Royal Society of Medicine 80, no. 11 (1987): 665–66. http://dx.doi.org/10.1177/014107688708001101.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Donald Acheson, E. "Breast Cancer Screening." Journal of the Royal Society of Medicine 82, no. 8 (1989): 455–57. http://dx.doi.org/10.1177/014107688908200804.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Owens, R. Glynn, and Jennifer J. Ashcroft. "Breast Cancer Screening." Journal of Psychosocial Oncology 4, no. 4 (1987): 15–26. http://dx.doi.org/10.1300/j077v04n04_02.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

GEMIGNANI, MARY L. "Breast Cancer Screening." Clinical Obstetrics and Gynecology 54, no. 1 (2011): 125–32. http://dx.doi.org/10.1097/grf.0b013e318208020d.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

FELDMAN, ELIZABETH D., BRIDGET A. OPPONG, and SHAWNA C. WILLEY. "Breast Cancer Screening." Clinical Obstetrics and Gynecology 55, no. 3 (2012): 662–70. http://dx.doi.org/10.1097/grf.0b013e31825ca884.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

EDDY, D. M. "Breast Cancer Screening." JNCI Journal of the National Cancer Institute 81, no. 3 (1989): 234–35. http://dx.doi.org/10.1093/jnci/81.3.234.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Palmieri, C., S. Fishpool, and H. O. Dickinson. "Breast cancer screening." BMJ 321, no. 7260 (2000): 567. http://dx.doi.org/10.1136/bmj.321.7260.567/b.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Witcombe, J. B. "Breast cancer screening." Clinical Radiology 44, no. 4 (1991): 287. http://dx.doi.org/10.1016/s0009-9260(05)80203-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Kirkpatrick, A. E. "Breast cancer screening." Clinical Radiology 44, no. 4 (1991): 287. http://dx.doi.org/10.1016/s0009-9260(05)80204-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Wilbanks, Sandy. "Breast Cancer Screening." Journal for Nurse Practitioners 13, no. 4 (2017): e217. http://dx.doi.org/10.1016/j.nurpra.2017.03.001.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Wilbanks, Sandy. "Breast Cancer Screening." Journal for Nurse Practitioners 13, no. 4 (2017): e219. http://dx.doi.org/10.1016/j.nurpra.2017.03.002.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Jatoi, Ismail. "Breast cancer screening." American Journal of Surgery 177, no. 6 (1999): 518–24. http://dx.doi.org/10.1016/s0002-9610(99)00096-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Fentiman, IanS. "BREAST CANCER SCREENING." Lancet 331, no. 8598 (1988): 1336. http://dx.doi.org/10.1016/s0140-6736(88)92149-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Autier, Philippe. "Breast cancer screening." European Journal of Cancer 47 (September 2011): S133—S146. http://dx.doi.org/10.1016/s0959-8049(11)70157-5.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Amadori, D. "Breast cancer screening." European Journal of Cancer 34 (September 1998): S91. http://dx.doi.org/10.1016/s0959-8049(98)80369-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Witcombe, J. B., Nicholas Wald, Christopher Frost, Howard Cuckle, and Peter Oppenheimer. "BREAST CANCER SCREENING." Lancet 329, no. 8537 (1987): 859. http://dx.doi.org/10.1016/s0140-6736(87)91632-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Moss, Sue, Jocelyn Chamberlain, Ruth Ellman, Anne Ludbrook, Anne Rodway, and A. F. Macdonald. "BREAST CANCER SCREENING." Lancet 329, no. 8542 (1987): 1153–54. http://dx.doi.org/10.1016/s0140-6736(87)91716-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Vanderburgh, David. "Breast cancer screening." Politics and the Life Sciences 37, no. 1 (2018): 135–40. http://dx.doi.org/10.1017/pls.2018.3.

Pełny tekst źródła

Streszczenie:

Cass R. Sunstein’s 2016 bookThe Ethics of Influence: Government in the Age of Behavioral Scienceprovides an extremely informative introduction to the science and ethics of the exercise of “influence” over others. As a longtime physician employed in both the public and private sectors, I now recognize that most of my formal training has been in the hard sciences, with little, if any, training in the appropriate influence of the decision-making processes of my patients and/or other health care professionals in institutional settings. Breast cancer screening is an excellent example of the conflic

Style APA, Harvard, Vancouver, ISO itp.

49

Jordan, Veronica, Muneeza Khan, and Donna Prill. "Breast Cancer Screening." Primary Care: Clinics in Office Practice 46, no. 1 (2019): 97–115. http://dx.doi.org/10.1016/j.pop.2018.10.010.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Thornton, Hazel. "Breast cancer screening." Lancet 351, no. 9096 (1998): 145. http://dx.doi.org/10.1016/s0140-6736(05)78108-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!